NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.
Don't have an account? Register
ADVERTISEMENT
ADVERTISEMENT
The HSE National Medication Safety Programme has asked the Medical Council to consider requiring medical students...
The HSE is undertaking “significant marketing overseas” to recruit consultants, including over 50 emergency medicine (EM)...
Capacity. The current “flu crisis” highlights how vulnerable the Irish healthcare system is to “shifts in...
Anxiety occurs in many forms and many circumstances. A certain amount of anxiety is normal and...
New Irish research has revealed the first-ever national data on the incidence of sudden unexpected death...
Dementia represents a looming crisis for Irish society: Approximately 64,000 people in Ireland are living with...
In November 2024, the European Medicines Agency (EMA) recommended the licensing of lecanemab (Leqembi) for early...
Migraine is the second most prevalent neurological disorder (after tension-type headache), with a female-to-male ratio of...
Last year, the American Headache Society (AHS) issued a position statement update on the use of...
Over the last decade the incidence of ultiple sclerosis (MS) has increased by approximately 30 per...
A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS),...
The investigation of gene therapy for brain tumour-related epilepsy (BTRE) was among the topics discussed at...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT